Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 814 results for "merck co"

Receive case studies from Merck Serono, Teva, MHRA, Cinfa Biotech GmbH, Selecta Biosciences, Norwegian Medicines Agency and more | Biosimilars and Biobetters
PRWeb

Receive case studies from Merck Serono, Teva, MHRA, Cinfa Biot...

London (PRWEB UK) 27 August 2015 SMi's 6th annual Biosimilars and Biobetters conference will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through ... PRWeb, 3 days ago

44 images for merck co

Octafinance, 3 days ago
PR inside, 6 days ago
Philly.com, 1 week ago
CTV News, 1 week ago
Octafinance, 2 weeks ago
Schaeffers Research, 5 days ago
FOXNews.com, 2 days ago
CTV News, 1 week ago
North Jersey.com, 1 month ago
ACQ Magazine, 1 week ago
Bioresearch Online

Samsung Bioepis And MSD Enter Biosimilars Development And Commercialization Agreement

Samsung Bioepis Co., Ltd. and MSD, known as Merck in the United States and Canada, announced today they have entered into an agreement to develop and commercialize multiple pre-specified and undisclosed biosimilar candidates. Samsung Bioepis has ...
 Bioresearch Online4 days ago
CTV News

Merck recalls chemotherapy drug over faulty child-proof caps

NEW YORK -- Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked. The Consumer Product Safety Commission said it doesn't know of any children who have been injured, but it's ...
 CTV News1 week ago Merck & Co. Recalls Temodar And Temozolomide Bottles With Cracked Caps Due To Failure To Meet Child-Resistant Closure Requirement  BioSpace1 week ago
Seeking Alpha

Merck's Pipeline Speaks Of Long-Term Health

Aug. 19, 2015 9:22 AM ET | About: Merck & Co Inc. (MRK) by: Summary Merck's revenue has been shrinking recently, and its outlook for 2015 isn't the best. However, as the pharma giant's pipeline continues to mature, investors should expect ...
 Seeking Alpha1 week ago
Seeking Alpha

Are You Paying Too Much For Merck?

Aug. 19, 2015 8:51 AM ET | About: Merck & Co Inc. (MRK) by: Summary We believe shares are currently worth ~$54 per share. Stagnant revenue and earnings growth may not justify current stock prices. Although the drug pipeline looks ...
 Seeking Alpha1 week ago
Seeking Alpha

AstraZeneca And Merck, Two Risk-Off Options In Immuno-Oncology

Aug. 17, 2015 1:24 PM ET | About: Merck & Co Inc. (MRK), Includes: AZN, MRTX by: Summary Whether you believe in a biotech bubble or not, a risk-off growth appeals to both sides. Immuno-oncology fits the profile both because the sector has ...
 Seeking Alpha1 week ago
InsiderMonkey.com

Merck & Co., Inc. (MRK), Monster Beverage Corp (MNST) Jump On Analyst Upgrades

Shares of Merck & Co., Inc. (NYSE: MRK ) and Monster Beverage Corp (NASDAQ: MNST ) have both moved upward today thanks tobullish ratings updates by major analysts. In a note published today, BMO Capital Markets upgraded Merck & Co., Inc. to ...
 InsiderMonkey.com2 weeks ago Merck (MRK) Stock Upgraded at BMO Capital Markets  TheStreet.com2 weeks ago Celebrity Chef Leticia Moreinos Schwartz, Merck and the American Diabetes Association Challenge Hispanics with Type 2 Diabetes to Get to Their A1C Goal  Sys-Con Media2 weeks ago BMO Capital Markets Upgrades Merck & Co. Inc (NYSE:MRK) to Outperform With $70.00 TP from Market Perform Rating  Octafinance2 weeks ago
[x]  

Merck (MRK) Showing Bullish Technicals With Resistance At $59.63

MarketIntelligenceCenter.com's patented algorithms have identified an attractive covered-call trade on Merck & Co Inc. (http://www.marketintelligencecenter.com/symbol/MRK"MRK). Look at the Jan. '16 $57.50 covered call for a net debit in the $55.81 ...
 Individual.com3 weeks ago Potential Merck (MRK) Trade Has 5.11% Downside Protection  Individual.com1 month ago Merck (MRK) Showing Bearish Technicals With Resistance At $58.81  Individual.com1 month ago Potential Merck (MRK) Trade Has 4.97% Downside Protection  Individual.com1 month ago
Cocorioko

Merck's Ebola Vaccine Found to Be Effective by Expert Panel

Merck & Co.'s vaccine for Ebola is highly effective, according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue. The vaccine was 100 percent effective when it was tested on more than 4,000 ...
 Bloomberg1 month ago In Interim Results from Phase 3 Study, Merck's Investigational Ebola Vaccine Efficacious; Study is Continuing  CNBC1 month ago In Interim Results From Phase III Study, Merck & Co. (MRK)'s Investigational Ebola Vaccine Efficacious; Study Is Continuing 7/31/2015  ClinicSpace4 weeks ago Stock Update (NYSE:MRK): In Interim Results from Phase 3 Study, Merck's Investigational Ebola Vaccine Efficacious; Study is Continuing  Jutia Group1 month ago
[x]  

Merck Raises Guidance

Merck & Co., Inc. (NYSE: MRK) said it expects 2015 earnings of $3.45 to $3.55 per share on revenue of $38.6 billion to $39.8 billion. The company's previous guidance was earnings of $3.35 to $3.48 per share and the current consensus earnings ...
 Individual.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less